Cargando…
Costs and cost-effectiveness of management of possible serious bacterial infections in young infants in outpatient settings when referral to a hospital was not possible: Results from randomized trials in Africa
INTRODUCTION: Serious bacterial neonatal infections are a major cause of global neonatal mortality. While hospitalized treatment is recommended, families cannot access inpatient treatment in low resource settings. Two parallel randomized control trials were conducted at five sites in three countries...
Autores principales: | Garg, Charu C., Tshefu, Antoinette, Longombe, Adrien Lokangaka, Kila, Jean-Serge Ngaima, Esamai, Fabian, Gisore, Peter, Ayede, Adejumoke Idowu, Falade, Adegoke Gbadegesin, Adejuyigbe, Ebunoluwa A., Anyabolu, Chineme Henry, Wammanda, Robinson D., Hyellashelni, Joshua Daba, Yoshida, Sachiyo, Gram, Lu, Nisar, Yasir Bin, Qazi, Shamim Ahmad, Bahl, Rajiv |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959374/ https://www.ncbi.nlm.nih.gov/pubmed/33720960 http://dx.doi.org/10.1371/journal.pone.0247977 |
Ejemplares similares
-
Clinical signs of possible serious infection and associated mortality among young infants presenting at first-level health facilities
por: Nisar, Yasir Bin, et al.
Publicado: (2021) -
Prevalence of clinical signs of possible serious bacterial infection and mortality associated with them from population-based surveillance of young infants from birth to 2 months of age
por: Puri, Dhruv, et al.
Publicado: (2021) -
Oral amoxicillin plus gentamicin regimens may be superior to the procaine-penicillin plus gentamicin regimens for treatment of young infants with possible serious bacterial infection when referral is not feasible: Pooled analysis from three trials in Africa and Asia
por: Longombe, Adrien Lokangaka, et al.
Publicado: (2022) -
Management of possible serious bacterial infection in young infants where referral is not possible in the context of existing health system structure in Ibadan, South-west Nigeria
por: Ayede, Adejumoke Idowu, et al.
Publicado: (2021) -
An open randomized clinical trial in comparing two artesunate-based combination treatments on Plasmodium falciparum malaria in Nigerian children: artesunate/sulphamethoxypyrazine/pyrimethamine (fixed dose over 24 hours) versus artesunate/amodiaquine (fixed dose over 48 hours)
por: Ayede, Idowu Adejumoke, et al.
Publicado: (2010)